Flynn Daniel Lee

CIK 00017137121 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001713712

Recent Transactions

50 trades

Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-06-16$14.40/sh−1,655→ 57,158 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-02-16$15.10/sh−1,370→ 58,813 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-02-15+16,488→ 60,183 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2023-02-15+65,900→ 65,900 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2023-01-17$21.24/sh−2,403→ 43,695 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-06-16$10.75/sh−1,768→ 46,098 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-02-16$9.05/sh−1,366→ 47,866 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-01-18+82,000→ 82,000 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2022-01-18+20,500→ 49,232 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2021-12-15+11,100→ 28,732 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-12-15+82,265→ 82,265 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2021-02-16+11,100→ 17,632 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-02-16+49,900→ 49,900 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2021-02-16$48.87/sh−508→ 6,532 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-08-10$1.89/sh+9,029→ 237,475 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-08-10−9,029→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-07-22−130,000→ 9,029 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-07-22$1.89/sh+130,000→ 228,446 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-02-18−42,190→ 42,190 total
Award
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-02-18+7,040→ 98,446 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-16−56,800→ 94,817 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-16$3.95/sh+10,106→ 34,606 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-16−10,106→ 29,444 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-16$6.13/sh+56,800→ 91,406 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-16−10,106→ 4,944 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-12$60.00/sh−31,029→ 35,750 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$1.89/sh+93,930→ 118,430 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$55.00/sh−28,822→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-10−28,822→ 107,827 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$55.00/sh−93,930→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$1.89/sh+28,822→ 53,322 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-10−93,930→ 13,897 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-09$55.00/sh−30,175→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-09−30,175→ 136,649 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-09$1.89/sh+30,175→ 54,675 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-11-11−143,185→ 166,824 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-11-11$1.89/sh+143,185→ 167,685 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-11-11$48.01/sh−143,185→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-11-08$1.89/sh+9,742→ 34,242 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-11-08−9,742→ 310,009 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-11-08$48.00/sh−9,742→ 24,500 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-10-28$40.00/sh−29,820→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-10-28−29,820→ 319,751 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-10-28$1.89/sh+29,820→ 54,320 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-08-13$42.90/sh−25,000→ 66,779 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-08-13$40.26/sh−93,395→ 54,212 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-08-13$1.89/sh+123,107→ 147,607 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-08-13−123,107→ 349,571 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-08-13$41.33/sh−29,712→ 24,500 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-02-21−24,500→ 15,050 total

Companies

Deciphera Pharmaceuticals, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD

WALTHAM, MA, 02451

View on SEC.gov